Saturday, October 3, 2026

Silver Futures Is 7% Up In The Last 21 Sessions

ViaNews Editorial Team

September 3, 2023

Silver Futures Is 7% Up In The Last 21 Sessions

(VIANEWS) - Silver (SI) has been up by 7.89% for the last 21 sessions. At 14:50 EST on Sunday, 3 September, Silver (SI) is $24.55.

Volume

Today's last reported volume for Silver is 60053, 99.99% below its average volume of 12137331663.44.

Volatility

Silver's last week, last month's, and last quarter's current intraday variation average was 0.92%, 0.39%, and 1.16%, respectively.

Silver's highest amplitude of average volatility was 0.92% (last week), 0.96% (last month), and 1.16% (last quarter), respectively.

Previous days news about Silver (SI)

  • Silver price analysis: rising wedge confirmation directs xag/usd sellers toward $24.00, US NFP eyed. According to FXStreet on Friday, 1 September, "With this, the Silver sellers appear well set to drop towards the 50-SMA level of around $24.15, a break of which could direct the XAG/USD toward the 200-SMA support of around $23.85.", "Even so, the tops marked during late July and the previous monthly high, respectively near $25.15 and $25.30, will act as the final defense of the Silver bears."
  • Silver price forecast: xag/usd turns volatile as investors assess the US NFP report. According to FXStreet on Friday, 1 September, "Upward-sloping 20-period Exponential Moving Average (EMA) continues to provide support to the Silver bulls."

More news about Silver (SI).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI-Driven Drug Development Meets Biotech Deal-Making and Regulatory Catalysts
AI-designed therapeutics (Insilico's rentosertib showing biological-age reductions) are moving into the clinical mainstream. Large-cap biotech is simultaneously reallocating capital through M&A (Lilly–Merida, $2.9B) and government funding (BARDA–Basilea), while trial failures (ziltivekimab, a 9.4% Novo Nordisk share drop) and upcoming FDA catalysts (the ivonescimab PDUFA on 2026-11-14) drive volatility. The wider AI regulatory and legal climate (Tesla Cybercab probe, xAI's Minnesota loss, OpenAI suits) is tightening, though QAIAx's micro-cap trial claims are speculative and weakly connected.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,327 source documents archived
Query this data → isubstrate.com
Silver Futures Is 7% Up In The Last 21 Sessions | Via News